Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

SWOG-8947 Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma

This study has been completed.
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Southwest Oncology Group Identifier:
First received: October 22, 2009
Last updated: May 17, 2013
Last verified: May 2013

RATIONALE: Collecting and storing samples of blood from patients with cancer to test in the laboratory may help the study of cancer in the future.

PURPOSE: This research study is collecting and storing blood samples from patients with previously untreated non-Hodgkin lymphoma.

Condition Intervention
Other: biologic sample preservation procedure

Study Type: Observational
Official Title: Central Lymphoma Serum Repository Protocol

Resource links provided by NLM:

Further study details as provided by Southwest Oncology Group:

Primary Outcome Measures:
  • Establishment of a Centralized Lymphoma Serum Repository for the Southwest Oncology Group [ Time Frame: July 2011 ]

Biospecimen Retention:   Samples With DNA
blood and serum for patients consenting to banking on lymphoma treatment studies

Enrollment: 939
Study Start Date: March 2005
Study Completion Date: July 2011
Primary Completion Date: July 2011 (Final data collection date for primary outcome measure)
Detailed Description:


  • To establish a central lymphoma serum repository that will serve as a resource to provide specimens for current and future scientific studies.
  • To utilize the Southwest Oncology Group clinical database to perform clinicopathologic correlations with the results of those studies.

OUTLINE: Serum is collected and stored for future correlative studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients consenting to 8947 banking of blood and serum


  • Diagnosis of non-Hodgkin lymphoma

    • Previously untreated disease
    • Patients must meet the eligibility criteria and be registered to a currently active Southwest Oncology Group-coordinated treatment protocol for previously untreated non-Hodgkin lymphoma


  • Not specified


  • See Disease Characteristics
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01000558

  Show 203 Study Locations
Sponsors and Collaborators
Southwest Oncology Group
National Cancer Institute (NCI)
Study Chair: Richard I. Fisher, MD James P. Wilmot Cancer Center
  More Information

Responsible Party: Southwest Oncology Group Identifier: NCT01000558     History of Changes
Other Study ID Numbers: CDR0000390329
SWOG-8947 ( Other Identifier: SWOG )
U10CA032102 ( US NIH Grant/Contract Award Number )
Study First Received: October 22, 2009
Last Updated: May 17, 2013

Keywords provided by Southwest Oncology Group:
non-Hodgkin lymphoma

Additional relevant MeSH terms:
Neoplasms by Histologic Type
Lymphoproliferative Disorders
Lymphatic Diseases
Immunoproliferative Disorders
Immune System Diseases processed this record on April 24, 2017